Business Description
Surgery Partners Inc
NAICS : 621493
SIC : 8099
ISIN : US86881A1007
Total Employee Number:
16,000Compare
Compare
Traded in other countries / regions
SGRY.USA1SP.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2015-10-01Description
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.39 | |||||
Debt-to-EBITDA | 7.05 | |||||
Interest Coverage | 1.66 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.78 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2 | |||||
3-Year EBITDA Growth Rate | -3.9 | |||||
3-Year EPS without NRI Growth Rate | 43.2 | |||||
3-Year FCF Growth Rate | 21.9 | |||||
3-Year Book Growth Rate | -5.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 20.35 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.05 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.07 | |||||
9-Day RSI | 49.29 | |||||
14-Day RSI | 52.67 | |||||
3-1 Month Momentum % | 12.73 | |||||
6-1 Month Momentum % | -4.78 | |||||
12-1 Month Momentum % | -33.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.86 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 13.15 | |||||
Days Sales Outstanding | 63.72 | |||||
Days Payable | 25.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -15.5 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.83 | |||||
Operating Margin % | 13.92 | |||||
Net Margin % | -2.28 | |||||
EBITDA Margin % | 17.1 | |||||
FCF Margin % | 6.22 | |||||
OCF Margin % | 8.37 | |||||
ROE % | -4.41 | |||||
ROA % | -0.95 | |||||
ROIC % | 5.39 | |||||
3-Year ROIIC % | 8.57 | |||||
ROC (Joel Greenblatt) % | 20.96 | |||||
ROCE % | 5.3 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 37.22 | |||||
PE Ratio without NRI | 42.67 | |||||
PS Ratio | 0.62 | |||||
PB Ratio | 1.29 | |||||
Price-to-Free-Cash-Flow | 10.19 | |||||
Price-to-Operating-Cash-Flow | 7.58 | |||||
EV-to-EBIT | 19.87 | |||||
EV-to-Forward-EBIT | 16.53 | |||||
EV-to-EBITDA | 13.67 | |||||
EV-to-Forward-EBITDA | 8.39 | |||||
EV-to-Revenue | 2.34 | |||||
EV-to-Forward-Revenue | 1.74 | |||||
EV-to-FCF | 37.57 | |||||
Price-to-GF-Value | 0.62 | |||||
Price-to-Projected-FCF | 0.78 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | 5.03 | |||||
FCF Yield % | 9.56 | |||||
Forward Rate of Return (Yacktman) % | -1.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SGRY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Surgery Partners Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,343.6 | ||
| EPS (TTM) ($) | -0.6 | ||
| Beta | 1.8549 | ||
| 3-Year Sharpe Ratio | -0.5 | ||
| 3-Year Sortino Ratio | -0.73 | ||
| Volatility % | 48.48 | ||
| 14-Day RSI | 52.67 | ||
| 14-Day ATR ($) | 0.69944 | ||
| 20-Day SMA ($) | 15.8755 | ||
| 12-1 Month Momentum % | -33.13 | ||
| 52-Week Range ($) | 11.41 - 24.1 | ||
| Shares Outstanding (Mil) | 130.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surgery Partners Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Surgery Partners Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 08:30 | In 118 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 117 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 08:30 | In 21 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 20 days | ||
| General meeting for 2026 | 2026-06-05 10:00 | 13.68 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-05 08:30 | 14.20 (-0.07%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 14.20 (-0.07%) | ||
| Barclays 28(th) Annual Global Healthcare Conference | 2026-03-10 14:30 | 13.30 (+1.37%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 08:30 | 15.88 (+2.98%) | ||
| Annual report for 2025 | 2026-03-02 | 15.50 (+1.11%) |
Show
Entries
Surgery Partners Inc Frequently Asked Questions
What is Surgery Partners Inc(SGRY)'s stock price today?
The current price of SGRY is $16.64. The 52 week high of SGRY is $24.10 and 52 week low is $11.41.
When is next earnings date of Surgery Partners Inc(SGRY)?
The next earnings date of Surgery Partners Inc(SGRY) is 2026-08-05 Est..
Does Surgery Partners Inc(SGRY) pay dividends? If so, how much?
Surgery Partners Inc(SGRY) does not pay dividend.
Guru Commentaries on NAS:SGRY
No articles.
Press Release
Articles on Surgery Partners Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers